Asembia AXS25: Becky Davis on GLP-1s
CRA consultant Becky Davis was interviewed at Asembia AXS25 Summit to highlight her presentation titled “GLP-1s: Riding the Wave of Innovative Medications.”
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Becky Davis is a principal in the Life Sciences Practice with more than 20 years of consulting experience with CRA, and a current focus on the healthcare and life sciences industry.
Her consulting experience focuses on US pricing, reimbursement, and market access issues across product development and portfolio lifecycles in a wide range of therapeutic areas. She brings deep expertise using payer, physician, and other stakeholder market research and data-driven insights to develop strategies for clients. She has considerable experience in navigating the dynamics associated with provider-administered products.
She has extensive project management experience and has worked on a diverse range of engagements, including strategic and business planning, market research / survey design, demand forecasting, competitive analysis, valuation, benchmarking, acquisition analysis, and pricing.
In addition to Life Sciences, she also has significant expertise in providing strategy consulting services in the metals, mining, aerospace, and manufactured parts industries.